The increasingly popular class of GLP-1 receptor and GIP dual medications, such as tirzepatide, semaglutide, and the recently introduced retatrutide, represent promising improvements in the management . https://semaglutide611377.estate-blog.com/42415356/retatrutide-the-detailed-review